Filed by Bowne Pure Compliance





Exhibit 10.31




SECURITIES EXCHANGE AGREEMENT




This SECURITIES EXCHANGE AGREEMENT (this “Agreement”), is entered into as of June 30,
2008, by and between ACROSS AMERICA REAL ESTATE CORP., a Colorado corporation (the
“Company”) and BOCO INVESTMENTS, LLC, a Colorado limited liability company (“BOCO”
or the “Buyer”).



RECITALS




A. On September 28, 2006, BOCO purchased 250,000 shares of the Company’s Series A Convertible
Preferred Stock (the “Preferred Stock”). The Preferred Stock is convertible into Common
Shares of the Company, $0.001 par value, at the election of BOCO on terms described in the Articles
of Incorporation of the Company.



B. On April 14, 2007, the Company entered into an agreement with BOCO to purchase $3,000,000
in Subordinated Revolving Notes (the “Revolving Notes”).



C. Subject to the terms and conditions set forth in this Agreement, BOCO desires to exchange
the Preferred Stock (and accrued dividends thereon) and the Revolving Notes (and accrued interest
thereon) for Common Shares, $0.001 par value, of the Company (the “Common Shares”).



D. The Company and BOCO are executing and delivering this Agreement in reliance upon the
exemption from securities registration afforded by the rules and regulations as promulgated by the
United States Securities and Exchange Commission (the “SEC”) under the Securities Act of
1933, as amended (the “1933 Act”).



NOW THEREFORE, in consideration of the mutual promises and covenants contained herein and for
other valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
Company and BOCO hereby agree as follows:




1. EXCHANGE OF PREFERRED STOCK AND REVOLVING NOTES.



a. Exchange of Preferred Stock. On the Closing Date, in exchange for the delivery by
BOCO and cancellation of 250,000 Preferred Shares and the waiver, cancellation and release of all
of BOCO’s right to receive dividends on such Preferred Shares, the Company shall issue and deliver
to BOCO 9,375,000 Common Shares.



b. Exchange of Revolving Notes . On the Closing Date, in exchange for the delivery by
BOCO and cancellation of the Revolving Notes and the waiver, cancellation and release of all of
BOCO’s right to receive interest accrued on such Revolving Notes, the Company shall issue and
deliver to BOCO 9,375,000 Common Shares.


 


 









 





c. Applicability of the Securities Purchase Agreement. The terms and conditions of the
Securities Purchase Agreement dated September 28, 2006 will remain in force and effect and shall apply to a new Revolving Note to be executed pursuant to a
contemporaneous Agreement of even date but shall not apply to a Senior Subordinated Note in the
amount of Three Million Five Hundred Thousand Dollars ($3,500,000) or a Revolving Note in the
amount of Three Million Five Hundred Thousand Dollars ($3,500,000) which are to be retired by that
said contemporaneous Agreement of even date or to the Series A Convertible Preferred Stock, which
are to be retired by this Agreement, provided however, that the Common Shares to be
issued pursuant to this Agreement shall not be “Conversion Shares” as that term is defined in the
Securities Purchase Agreement.




2. CLOSING AND EXCHANGE




a. Exchange. Subject to the satisfaction (or written waiver) of the
conditions thereto set forth in Section 6, the exchange of the Common Shares for the
Revolving Notes (and accrued interest) and the Preferred Stock (and accrued
dividends) (the “Closing”) shall take place at such date and time as is
mutually agreed by the Company and BOCO (such date, the “Closing Date”).
The Closing shall occur at the offices of the Company, 700 Seventeenth Street, Suite
1200, Denver, Colorado 80202, or at such other place as the Company and BOCO may
designate. On the Closing Date, against delivery by the Company of the share
certificates representing the Common Shares, BOCO shall proffer the Preferred Stock
and the Revolving Notes (together, the “Purchase Price”) to the Company; and
the Company shall pay directly or reimburse the Buyer for all Buyer Expenses as
provided in Section 5(d).



d. Shareholders Agreement. Effective at the Closing, the Company, BOCO and GDBA shall
enter into an Amended and Restated Shareholders Agreement in a form to be agreed by the parties,
which supersedes the Shareholders Agreement dated September 28, 2006.




3. BUYER’S REPRESENTATIONS AND WARRANTIES. BOCO represents and warrants to the Company
that:



e. Investment Purpose. As of the date hereof, the Buyer is acquiring the Common
Shares for its own account and not with a present view towards the public sale or distribution
thereof; provided, however, that by making the representations herein, the Buyer
does not agree to hold any of the Securities for any minimum or other specific term and reserves
the right to dispose of the Securities at any time in accordance with or pursuant to a registration
statement or an exemption under the 1933 Act.



f. Accredited Investor Status. The Buyer is an “accredited investor” as that term is
defined in Rule 501(a) of Regulation D promulgated under the 1933 Act.



g. Reliance on Exemptions. The Buyer understands that the Common Shares are being
offered and sold to it in reliance upon specific exemptions from the registration requirements of
United States federal and state securities laws and that the Company is relying upon the truth and
accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
Securities.


 


2









 





h. Information. The Buyer acknowledges that it has been afforded the opportunity to
ask questions and receive answers concerning the Company and to obtain additional information that
it has requested to verify the accuracy of the information contained herein. Neither the foregoing
nor any due diligence investigation conducted by Buyer or any of its advisors or representatives
shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties
contained in Section 4 below. The Buyer understands that its investment in the Common Shares
involves a significant degree of risk.



i. Governmental Review. The Buyer understands that no United States federal or state
agency or any other government or governmental agency has passed upon or made any recommendation or
endorsement of the Common Shares.



j. Transfer or Resale. The Buyer understands that (i) the sale or resale of the
Common Shares has not been and is not being registered under the 1933 Act or any applicable state
securities laws, and the Common Shares may not be transferred unless (a) the Common Shares are sold
pursuant to an effective registration statement under the 1933 Act, (b) the Buyer shall have
delivered to the Company an opinion of counsel reasonably acceptable to the Company and its counsel
that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration or (c) such Buyer provides the Company with reasonable assurance that such
Common Shares can be sold, assigned or transferred pursuant to Rule 144 promulgated under the 1933
Act (or any successor rule thereto) (“Rule 144”); (ii) any sale of such Common Shares made
in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if
Rule 144 is not applicable, any resale of such Common Shares under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that
term is defined in the 1933 Act) may require compliance with some other exemption under the 1933
Act or the rules and regulations of the SEC thereunder; and (iii) neither the Company nor any other
person is under any obligation to register such Common Shares under the 1933 Act or any state
securities laws or to comply with the terms and conditions of any exemption thereunder.
Notwithstanding the foregoing or anything else contained herein to the contrary, the Common Shares
may be pledged as collateral in connection with a bona fide margin account or other lending
arrangement.



k. Legends. The certificates evidencing the Common Shares will bear a restrictive
legend in substantially the following form (and a stop-transfer order may be placed against
transfer of the certificates for such Common Shares):



“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE
SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID
ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE
CUSTOMARY FOR OPINIONS OF COUNSEL IN
COMPARABLE TRANSACTIONS, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.”


 


3









 





The legend set forth above shall be removed and the Company shall issue a certificate without
such legend to the holder of any certificate upon which it is stamped, if, unless otherwise
required by applicable state securities laws, (a) such Common Shares are registered for resale
under the 1933 Act, (b) such holder provides the Company with an opinion of counsel, which opinion
shall be reasonably acceptable to the Company’s counsel, to the effect that the sale or transfer of
such Common Shares may be made without registration under the 1933 Act, or (c) such holder provides
the Company with reasonable assurances that such Common Shares have been or are being sold pursuant
to Rule 144. The Buyer agrees to sell all Common Shares, including those represented by a
certificate(s) from which the legend has been removed, in compliance with applicable prospectus
delivery requirements, if any.



l. Authorization; Enforcement. The Agreements to which such Buyer is a party have
been duly and validly authorized, executed and delivered on behalf of the Buyer, and each Agreement
constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.



m. Residency. The Buyer is a resident of the jurisdiction set forth immediately below
such Buyer’s name on the signature pages hereto.



2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company represents and warrants to
Buyer that:



a. Organization and Qualification. The Company is duly organized, validly existing
and in good standing under the laws of Colorado, with full power and authority to own, lease, use
and operate its properties and to carry on its business as and where now owned, leased, used,
operated and conducted.



b. Authorization; Enforcement. (i) The Company has all requisite corporate power and
authority to enter into and perform the Agreements, to consummate the transactions contemplated
hereby and thereby and to issue the Common Shares in accordance with the terms hereof and thereof,
(ii) the execution and delivery of the Agreements and the Common Shares by the Company and the
consummation by it of the transactions contemplated hereby and thereby (including without
limitation, the issuance of the Common Shares) have been duly authorized by the Company’s Board of
Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, (iii) the Agreements have been duly executed and delivered by the Company
by its authorized representative, and such authorized representative is the true and official
representative with authority to sign the Agreements and the other documents executed in connection
herewith and bind the Company accordingly, and (iv) each of the Agreements constitutes the legal,
valid and binding obligation of the Company enforceable against the Company in accordance with its
terms.


 


4









 





c. Capitalization. Before giving effect to the transactions to be effected at the
Closing, the authorized capital stock of the Company consists of (i) 50,000,000 shares of Common Stock, of which 16,036,625 shares are issued and outstanding, and 2,068,000 shares are
reserved for issuance upon conversion of the Preferred Stock; and (ii) 483,000 shares of
undesignated preferred stock, of which 517,000 have been designated Series A Convertible Preferred
Stock and are issued and outstanding. All of such outstanding shares of capital stock are duly
authorized, validly issued, fully paid and nonassessable. No shares of capital stock of the
Company are subject to preemptive rights or any other similar rights of the shareholders of the
Company or any liens or encumbrances imposed through the actions or failure to act of the Company.
Except as disclosed in Schedule 4(c), as of the effective date of this Agreement, (i) there
are no outstanding options, preferred stock, scrip, rights to subscribe for, puts, calls, rights of
first refusal, agreements, understandings, claims or other commitments or rights of any character
whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of
capital stock of the Company, or arrangements by which the Company is or may become bound to issue
additional shares of capital stock of the Company, (ii) there are no agreements or arrangements
under which the Company is obligated to register the sale of any of its or their securities under
the 1933 Act and (iii) there are no anti-dilution or price adjustment provisions contained in any
security issued by the Company (or in any agreement providing rights to security holders) that will
be triggered by the issuance of the Common Shares. The Company has furnished to the Buyer true and
correct copies of the Company’s Articles of Incorporation as in effect on the date hereof
(“Articles of Incorporation”), the Company’s Bylaws, as in effect on the date hereof (the
“Bylaws”), and the terms of all securities convertible into or exercisable for Common Stock
of the Company and the material rights of the holders thereof in respect thereto.



d. Issuance of Shares. The issuance of the Common Shares has been duly authorized and
at the Closing, the Common Shares will be validly issued, fully paid and non-assessable, and free
from all taxes, liens, claims and encumbrances with respect to the issuance thereof and shall not
be subject to preemptive rights or other similar rights of shareholders of the Company and will not
impose personal liability upon the holder thereof.



e. Acknowledgment of Dilution. The Company understands and acknowledges the dilutive
effect to the existing common shares upon the issuance of the Common Shares hereunder.



f. No Conflicts. The execution, delivery and performance of the Agreements, the
issuance of the Common Shares to be issued by the Company and the consummation by the Company of
the transactions contemplated hereby and thereby will not (i) conflict with or result in a
violation of any provision of the Articles of Incorporation or Bylaws or (ii) violate or conflict
with, or result in a breach of any provision of, or constitute a default (or an event which with
notice or lapse of time or both could become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any contract, commitment, agreement,
indenture or instrument to which the Company is a party, or (iii) result in a violation of any law,
rule, regulation, order, judgment or decree (including federal and state securities laws and
regulations and regulations of any self-regulatory organizations to which the Company or its
securities are subject) applicable to the Company or by which any property or asset of the Company
is bound or affected, except with respect to clause (ii) and (iii) only, for such conflicts,
defaults, terminations, amendments, accelerations, cancellations and violations as could not
reasonably be expected, individually or in the aggregate, to have a Material Adverse



 


5









 






Effect. Neither the Company nor any of its Subsidiaries is in violation of its Articles of
Incorporation, Bylaws or other organizational documents and neither the Company nor any of its
Subsidiaries is in default (and no event has occurred which with notice or lapse of time or both
could put the Company or any of its Subsidiaries in default) under, and neither the Company nor any
of its Subsidiaries has taken any action or failed to take any action that would give to others any
rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its Subsidiaries is a party or by which any property or
assets of the Company or any of its Subsidiaries is bound or affected, except for possible defaults
as could not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. Except as set forth on Schedule 4(f), the Company is not required to obtain any
consent, authorization or order of, or make any filing or registration with, any court,
governmental agency, regulatory agency, self regulatory organization or stock market or any third
party in order for it to execute, deliver or perform any of its obligations under the Agreements,
to issue the Common Shares. Except as set forth in Schedule 4(f), all consents,
authorizations, orders, filings and registrations which the Company is required to obtain pursuant
to the preceding sentence have been obtained or effected on or prior to the date hereof.



g. Trading. The Company’s Common Stock is traded on the Over-the-Counter Bulletin
Board under the symbol AARD.OB (the “OTCBB”). The Company is not in violation of the
quotation requirements of the OTCBB and does not reasonably anticipate that the Common Stock will
be removed by the OTCBB in the foreseeable future. To the Company’s Knowledge, there are no facts
or circumstances which might give rise to any of the foregoing.



h. SEC Documents; Financial Statements. The Company’s Common Stock is registered
under Section 12(g) of the 1934 Act. Except as disclosed in Schedule 4(h), the Company has
timely filed all reports, schedules, forms, statements and other documents required to be filed by
it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing filed
prior to the date hereof and all exhibits included therein and financial statements and schedules
thereto and documents (other than exhibits to such documents) incorporated by reference therein,
being hereinafter referred to herein as the “SEC Documents”). As of their respective
dates, the financial statements of the Company included in the SEC Documents (the “Financial
Statements”) complied as to form in all material respects with applicable accounting
requirements and the published rules and regulations of the SEC with respect thereto. The
Financial Statements have been prepared in accordance with United States generally accepted
accounting principles, consistently applied, during the periods involved (except (i) as may be
otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of
unaudited interim statements, to the extent they may not include footnotes) and fairly present in
all material respects the consolidated financial position of the Company and its consolidated
Subsidiaries as of the dates thereof and the consolidated results of their operations and cash
flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments).



i. No Undisclosed Liabilities. The Company does not have any Liabilities, except for
(a) Liabilities reflected on the face of the liabilities section of the Company’s balance sheet at
March 31, 2008 as filed with the Company’s Form 10-QSB for the quarter ended March 31, 2008 (b)
Liabilities under agreements, contracts, commitments, licenses or leases which have arisen since March 31, 2008 in the ordinary course of business, and (c) Liabilities set forth
on Schedule 4(i).


 


6









 





j. Absence of Certain Changes. Except as set forth in Schedule 4(j), since
March 31, 2008, (i) the Company has been operated in the ordinary course, and (ii) there has
occurred no fact, event or circumstance that, individually or in the aggregate, has or could
reasonably be expected to have a Material Adverse Effect.



k. Absence of Litigation. Except as set forth on Schedule 4(k), there is no
action, suit, claim, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the Knowledge of the
Company, threatened against or affecting the Company, or their officers or directors in their
capacity as such. To the Knowledge of the Company there are no facts or circumstances which might
give rise to any of the foregoing.



l. No Materially Adverse Contracts, etc. Neither the Company nor any of its
Subsidiaries is subject to any charter, corporate or other legal restriction, or any judgment,
decree, order, rule or regulation which has or could reasonably be expected to have a Material
Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract or
agreement which has or could reasonably be expected to have a Material Adverse Effect.



m. Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges
and agrees that each Buyer is acting solely in the capacity of arm’s length purchasers with respect
to this Agreement and the transactions contemplated hereby. The Company further acknowledges that
no Buyer is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to this Agreement and the transactions contemplated hereby and any statement made by
any Buyer or any of their respective representatives or agents in connection with this Agreement
and the transactions contemplated hereby is not advice or a recommendation and is merely incidental
to the Buyer’s purchase of the Securities. The Company further represents to each Buyer that the
Company’s decision to enter into this Agreement has been based solely on the independent evaluation
of the Company and its representatives.



n. No Integrated Offering. Neither the Company, nor any of its affiliates, nor any
person acting on its or their behalf, has directly or indirectly made any offers or sales in any
security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Common Shares to the Buyer. The issuance of
the Common Shares to the Buyer will not be integrated with any other issuance of the Company’s
securities (past, current or future) for purposes of any shareholder approval provisions applicable
to the Company or its securities.



o. No Brokers. Except as set forth in Schedule 4(o), the Company has taken no
action which would give rise to any claim by any person for brokerage commissions, transaction fees
or similar payments relating to this Agreement or the transactions contemplated hereby.


 


7









 





p. Compliance With Law. The Company has complied with all applicable laws, statutes,
rules, regulations or orders of any governmental authority and no proceeding or investigation is
pending, or to the Knowledge of the Company, threatened, alleging any failure to so comply.



q. Disclosure. No event or circumstance has occurred or exists with respect to the
Company or any of its Subsidiaries or its or their business, properties, prospects, operations or
financial conditions, which, under applicable law, rule or regulation, requires public disclosure
or announcement by the Company but which has not been so publicly announced or disclosed.




3. COVENANTS.



a. Best Efforts. The Company and the Buyer shall each use their best efforts to
satisfy timely each of the conditions described in Section 6 and 7 of this Agreement and to do all
things necessary, proper and advisable in order to consummate and make effective the transactions
contemplated by this Agreement.



b. Form D; Blue Sky Laws. The Company agrees to file a Form D with respect to the
Common Shares as required under Regulation D and to provide a copy thereof to Buyer promptly after
such filing. The Company shall, on or before the Closing Date, take such action as the Company
shall reasonably determine is necessary to qualify the Securities for sale to the Buyer at the
Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of
the United States (or to obtain an exemption from such qualification), and shall provide evidence
of any such action so taken to each Buyer on or prior to the Closing Date.



c. Disclosure. The Company shall issue a press release describing the material terms
of the transaction contemplated hereby as soon as practicable following the Closing Date but in no
event more than four (4) business days after the Closing Date, which press release shall be subject
to prior review by the Buyer. The Company agrees that such press release shall not disclose the
name of the Buyer unless expressly consented to in writing by the Buyer or unless required by
applicable law or regulation, and then only to the extent of such requirement. The Company has not
disclosed to the Buyer any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly following such disclosure
to the Buyer.



d. Expenses. At the Closing, the Company shall pay directly or reimburse the Buyer
for all expenses incurred by the Buyer in connection with the negotiation, preparation, execution,
delivery and performance of the Agreements, including, without limitation, attorneys’ and
consultants’ fees and expenses, transfer agent fees, fees for stock quotation services, fees
relating to any amendments or modifications of the Agreements or any consents or waivers required
to be obtained by Buyer in connection with this transaction (the “Buyer Expenses”). On or
before the Closing Date, Buyer shall submit to the Company a schedule of Buyer Expenses that have
been incurred by such Buyer, which schedule shall specify the amounts to be paid by the Company
directly on behalf of the Buyer and amounts to be paid by the Company to the Buyer in reimbursement
of amounts expended by the Buyer. Notwithstanding anything herein to the contrary, the Company’s obligation to pay or reimburse the Buyer Expenses shall not
exceed $5,000 for the Buyer.


 


8









 





e. No Integration. The Company shall not make any offers or sales of any security
(other than the Securities) under circumstances that would require registration of the Securities
being offered or sold hereunder under the 1933 Act or cause the offering of the Securities to be
integrated with any other offering of securities by the Company for the purpose of any stockholder
approval provision applicable to the Company or its securities.




4. CLOSING DATE CONDITIONS PRECEDENT



a. Conditions to the Company’s Obligation to Sell. The obligation of the Company
hereunder to issue Common Shares to Buyer at the Closing is subject to the satisfaction, at or
before the Closing Date of each of the following conditions thereto, provided that these conditions
are for the Company’s sole benefit and may be waived by the Company at any time in its sole
discretion:




(ii) The Buyer shall have executed the Agreements and delivered the same to the Company.



(iii) The Buyer shall have delivered its Preferred Stock and Revolving Notes in accordance
with Section 1 above.



(iv) The representations and warranties of the Buyer shall be true and correct in all material
respects as of the date when made and as of the Closing Date as though made at that time (except
for representations and warranties that speak as of a specific date), and the Buyer shall have
performed, satisfied and complied in all material respects with the covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at
or prior to the Closing Date.



(v) No litigation, statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
authority of competent jurisdiction or any self-regulatory organization having authority over the
matters contemplated hereby which is reasonably expected to restrain, prohibit or invalidate
transactions contemplated by this Agreement.



b. Conditions to the Buyer’s Obligation to Acquire. The obligations of Buyer
hereunder to acquire the Common Shares at the Closing is subject to the satisfaction, at or before
the Closing Date of each of the following conditions, provided that these conditions are for
Buyer’s sole benefit and may be waived by Buyer at any time in its sole discretion:




(ii) The Company shall have executed the Agreements and delivered the same to the Buyer.



(iii) The Company shall have delivered to Buyer a certificate representing such number of
shares of Common Shares as set forth in Section 1.


 


9









 





(iv) No event shall have occurred which has had or which could reasonably be expected to have
a Material Adverse Effect on the Company.




5. SURVIVAL AND INDEMNIFICATION.



a. Survival. The representations and warranties of the Company and the agreements and
covenants set forth in Sections 4 and 5 shall survive the Closing notwithstanding any due diligence
investigation conducted by or on behalf of the Buyer.



b. Indemnification. The Company shall defend, protect, indemnify and hold harmless
Buyer and all of Buyer’s partners, members, officers, directors, employees and direct or indirect
investors and any of such Buyer’s agents or other representatives (including, without limitation,
those retained in connection with the transactions contemplated by this Agreement) (collectively,
the “Indemnitees”) from and against any and all actions, causes of action, suits, claims,
losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith
(irrespective of whether any such Indemnitee is a party to the action for which indemnification
hereunder is sought), and including reasonable attorneys’ fees and disbursements (the
“Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising out of,
or relating to (a) any misrepresentation or breach of any representation or warranty made by the
Company in the Agreements or any other certificate, instrument or document contemplated hereby or
thereby, (b) any breach of any covenant, agreement or obligation of the Company contained in the
Agreements or any other certificate, instrument or document contemplated hereby or thereby or (c)
any cause of action, suit or claim brought or made against such Indemnitee by a third party
(including for these purposes a derivative action brought on behalf of the Company) and arising out
of or resulting from (i) the execution, delivery, performance or enforcement of the Agreements or
any other certificate, instrument or document contemplated hereby or thereby, or (ii) the status of
Buyer as an investor in the Company. To the extent that the foregoing undertaking by the Company
may be unenforceable for any reason, the Company shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law.




6. DEFINITIONS.




“1934 Act” means the Securities and Exchange Act of 1934, as amended.



“Agreements” means this Agreement, the Amended and Restated Shareholders Agreement,
the Securities Purchase Agreement (to the extent that the terms survive as contemplated by Section
1(c)), the Accrued Interest Agreement, and any other agreements or instruments to be executed in
connection with the transactions contemplated by this Agreement.



“Business Day” means any day other than a Saturday, Sunday or a day on which
commercial banks in the city of Denver, Colorado are authorized or required by law or executive
order to remain closed.




“Closing” has the meaning set forth in Section 2.



“Closing Date” has the meaning set forth in Section 2.


 


10









 





“Knowledge” means a Person’s actual knowledge. For the purposes of this Agreement,
the “Company’s Knowledge” or “Knowledge of the Company” means the knowledge of Peter Shepard or
James W. Creamer III.



“Liability” means any liability or obligation, whether known or unknown, asserted or
unasserted, absolute or contingent, accrued or unaccrued, liquidated or unliquidated and whether
due or to become due, regardless of when asserted.



“Material Adverse Effect” means (i) a material and adverse effect on the business,
assets, liabilities, results of operations, assets, prospects, business or condition (financial or
otherwise) of the Company and the Subsidiaries, taken as a whole, or (ii) an adverse impairment to
the Company’s ability to perform under any of its obligations under the Agreements.



“Person” means a natural person or any corporation, limited liability company or other
entity.




“SEC Documents” has the meaning set forth in Section 4(h).



“Subsidiaries” means any corporation or other organization, whether incorporated or
unincorporated, in which the Company owns, directly or indirectly, any ownership interest.




7. GOVERNING LAW; MISCELLANEOUS.



a. Governing Law. This Agreement shall be enforced, governed by and construed in
accordance with the laws of the State of Colorado applicable to agreements made and to be performed
entirely within such state, without regard to the principles of conflict of laws. The parties
hereto hereby submit to the exclusive jurisdiction of federal or state courts located in Denver,
Colorado with respect to any dispute arising under this Agreement, the agreements entered into in
connection herewith or the transactions contemplated hereby or thereby. Both parties irrevocably
waive the defense of an inconvenient forum to the maintenance of such suit or proceeding. Both
parties further agree that service of process upon a party mailed to the notice address set forth
in Section 9(f) (or such other address specified in writing) by registered first class mail shall
be deemed in every respect effective service of process upon the party in any such suit or
proceeding. Nothing herein shall affect either party’s right to serve process in any other manner
permitted by law. Both parties agree that a final non-appealable judgment in any such suit or
proceeding shall be conclusive and may be enforced in other jurisdictions by suit on such judgment
or in any other lawful manner. The party which does not prevail in any dispute arising under this
agreement shall be responsible for all fees and expenses, including reasonable attorneys’ fees,
incurred by the prevailing party in connection with such dispute.



b. Counterparts; Signatures by Facsimile. This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original but all of which shall constitute one
and the same agreement and shall become effective when counterparts have been signed by each party
and delivered to the other party. This Agreement, once executed by a party, may be delivered to
the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature
of the party so delivering this Agreement.


 


11









 





c. Headings. The headings of this Agreement are for convenience of reference only and
shall not form part of, or affect the interpretation of, this Agreement.



d. Severability. In the event that any provision of this Agreement is invalid or
unenforceable under any applicable statute or rule of law, then such provision shall be deemed
inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provision hereof.



e. Entire Agreement; Amendments. This Agreement and the instruments referenced herein
contain the entire understanding of the parties with respect to the matters covered herein and
therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer
makes any representation, warranty, covenant or undertaking with respect to such matters. No
provision of this Agreement may be waived or amended other than by an instrument in writing signed
by the party to be charged with enforcement.



f. Notices. Any notices required or permitted to be given under the terms of this
Agreement shall be sent by certified or registered mail (return receipt requested) or delivered
personally or by courier (including a recognized overnight delivery service) or by facsimile and
shall be effective five days after being placed in the mail, if mailed by regular United States
mail, or upon receipt, if delivered personally or by courier (including a recognized overnight
delivery service) or by facsimile, in each case addressed to a party. The addresses for such
communications shall be:




If to the Company:




Across America Real Estate Corp.

700 Seventeenth Street, Suite 1200

Denver, Colorado 80202

Attention: Chief Executive Officer

Telephone: (303) 893-1003

Facsimile: (303) 893-1005




With a copy to:




David Wagner & Associates, P.C.

8400 East Prentice Ave.

Penthouse Suite

Greenwood Village, Colorado 80111

Attention: David J. Wagner, Esq.

Telephone: (303) 793-0304

Facsimile: (303) 409-7650


 


12









 






If to a Buyer:




BOCO Investments, LLC

103 West Mountain Ave.

Fort Collins, Colorado 80524

Facsimile: (970) 482-6139

Attention: Chief Executive Officer




With a copy to:




Davis Graham & Stubbs LLP

1550 17th Street, Suite 500

Denver, Colorado 80202

Attention: Brian J. Boonstra

Telephone: (303) 892-9400

Facsimile: (303) 892-7400




Each party shall provide notice to the other party of any change in address.



g. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and assigns. Neither the Company nor any Buyer shall
assign this Agreement or any rights or obligations hereunder without the prior written consent of
the other. Notwithstanding the foregoing, subject to the limitations of this Agreement, Buyer may
assign its rights hereunder to any person that purchases Securities in a private transaction from a
Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without the
consent of the Company.



h. Third Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective permitted successors and assigns, and is not for the benefit
of, nor may any provision hereof be enforced by, any other person.



i. Further Assurances. Each party shall do and perform, or cause to be done and
performed, all such further acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as the other party may reasonably request in
order to carry out the intent and accomplish the purposes of this Agreement and the consummation of
the transactions contemplated hereby.



j. No Strict Construction. The language used in this Agreement will be deemed to be
the language chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party.



[signature page follows]





 


13









 







IN WITNESS WHEREOF, the Buyer and the Company have caused this Agreement to be duly executed
as of the date first above written.



	 	 	 
	ACROSS AMERICA REAL ESTATE CORP.

	 	 
	 
	 	 
	/s/
	 	 
	 
	 	 
	Name: Peter Shepard
	 	 
	Title: Chief Executive Officer
	 	 
	 
	 	 
	BOCO INVESTMENTS, LLC
	 	 
	 
	 	 
	/s/
	 	 
	 
	 	 
	Name: Joseph C. Zimlich
	 	 
	Title: CEO
	 	 
	RESIDENCE: Colorado